RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
The most common chronic myeloproliferative disorder characterized by neutrophilic leukocytosis. It is associated with the Philadelphia (Ph) chromosome and/or the BCR/ABL fusion gene. Most patients are middle-aged or elderly. Common findings at presentation include fatigue, weight loss, anemia, night sweats, and splenomegaly. The disease is bi- or triphasic: an initial indolent chronic phase is followed by accelerated or blast phase. Allogeneic bone marrow transplantation is currently the only curative therapy (adapted from WHO 2001).
View Complete Description Individual Studies |
|
|---|---|
|
|
Authors: Kazuhito Naka, Takayuki Hoshii, Teruyuki Muraguchi, Yuko Tadokoro, Takako Ooshio, Yukio Kondo, Shinji Nakao, Noboru Motoyama, Atsushi Hirao
Nature 2010 Feb 4Authors: Rüdiger Hehlmann, Andreas Hochhaus, Michele Baccarani, European LeukemiaNet
Lancet 2007 Jul 28Thought leaders and organizations working on research involving chronic myeloid leukaemia.
conditions: Chronic Myeloid Leukaemia
interventions: Glivec ; Interferon
conditions: Chronic Myeloid Leukemia
interventions: SV40 vectors carrying siRNA
Praticien Hospitalier
University Hospital
No NextBio groups were found for “chronic myeloid leukaemia”.
Be the first to
start
a group and share your interests with others within the NextBio community.